Drug Type Interferons |
Synonyms- |
Target |
Mechanism IFNAR agonists(Interferon alpha/beta receptor agonists), Immunostimulants, Innate antiviral immune response inducers |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date CN (01 Jan 1999), |
Regulation- |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Basal Cell Carcinoma | CN | 01 Jan 1999 | |
Bladder Cancer | CN | 01 Jan 1999 | |
Condylomata Acuminata | CN | 01 Jan 1999 | |
Hairy Cell Leukemia | CN | 01 Jan 1999 | |
Hepatitis, Viral, Human | CN | 01 Jan 1999 | |
Herpes Zoster | CN | 01 Jan 1999 | |
Kaposi Sarcoma | CN | 01 Jan 1999 | |
Melanoma | CN | 01 Jan 1999 | |
Multiple Myeloma | CN | 01 Jan 1999 | |
Ovarian Cancer | CN | 01 Jan 1999 | |
Philadelphia chromosome positive chronic myelogenous leukemia | CN | 01 Jan 1999 | |
Renal Cell Carcinoma | CN | 01 Jan 1999 |